OPQ’s State of Pharmaceutical Quality Report Is a Data Bonanza (with Cameos by Eye Drops and Hand Sanitizers) By Kalie E. Richardson & John W.M. Claud —

https://mail.google.com/mail/u/0/#inbox/FMfcgzQVxHZZrLZRgzDNZmNTNtSfdPMT FDA’s Office of Pharmaceutical Quality (OPQ) in the Center for Drug Evaluation and Research (CDER) is charged with assuring that drugs marketed in the U.S. are safe, effective, and meet appropriate quality standards. While no office at FDA truly works in a vacuum, we can safely call OPQ the tip of FDA’s quality spear.